Found 62 matching trials
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache
PHASE4This study's hypothesis is the 4mg StatDose sumatriptan is effective for th...
Location
Diamond Headache Clinic
Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers
PHASE1the trial is a randomized, open label, crossover, single-administration bio...
Location
Multiple Locations
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
PHASE3The purpose of this study is to determine the consistency of response for T...
Location
GSK Investigational Site
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
PHASE4The investigators propose to test the efficacy of ketorolac nasal spray ver...
Location
The Johns Hopkins Bayview Headache Center
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
PHASE2This study proposes to compare the efficacy of sumatriptan and aspirin to p...
Location
South Drive Medical Clinic
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
PHASE3The purpose of this study is to determine the consistency of response for T...
Location
GSK Investigational Site
Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects
PHASE1The purpose of this study is:
* To compare the single-dose pharmacokinetic...
Drug and Non-Drug Treatment Of Severe Migraine
PHASE4The purpose of this study is to determine if the addition of preventive med...
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
PHASE3This study will be conducted to evaluate the safety and efficacy of sumatri...
Location
Phoenix Children's Hospital
Study of NXN 188 for the Treatment of Migraine With Aura
PHASE2NXN-188 Dihydrochloride is being developed as an immediate release oral pro...
Location
C. Philip O'Carrroll, MD, Inc.